Cohen, R., Bennouna, J., Meurisse, A., Tournigand, C., De La Fouchardière, C., Tougeron, D., Borg, C., Mazard, T., Chibaudel, B., Garcia-Larnicol, M., Svrcek, M., Vernerey, D., Menu, Y., & André, T. (2020). rECIST and iRECIST criteria for the evaluation of nivolumab plus ipilimumab in patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the GERCOR NIPICOL phase II study. Journal for immunotherapy of cancer, 8(2), . http://access.bl.uk/ark:/81055/vdc_100150404095.0x000006